Benitec Biopharma Sales General And Administrative To Revenue Over Time
| BNTC Stock | USD 9.85 0.30 2.96% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Benitec Biopharma Performance and Benitec Biopharma Correlation. Benitec |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.51) | Revenue Per Share 0.003 | Quarterly Revenue Growth 0.125 | Return On Assets (0.50) | Return On Equity (0.92) |
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Sales General And Administrative To Revenue Analysis
Compare Benitec Biopharma and related stocks such as Bio Path Holdings, Catalyst Biosciences, and Diffusion Pharmaceuticals Sales General And Administrative To Revenue Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BPTH | 232 | 232 | 232 | 232 | 232 | 232 | 232 | 95.2162 | 95.2162 | 95.2162 | 95.2162 | 95.2162 | 95.2162 | 110 | 180 |
| CAPR | 2.5482 | 1.5627 | 8.244 | 4.3895 | 0.6304 | 1.1579 | 1.5464 | 3.4835 | 2.9507 | 3.5791 | 17.8669 | 31.0835 | 4.0927 | 0.4911 | 0.47 |
| NXTC | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 1.5146 | 0.7619 | 0.7619 | 0.7619 | 0.88 | 1.25 |
| ALRN | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.306 | 0.28 | 0.25 |
| ZURA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ZVSA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| APLM | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 6.0082 | 7.6 K | 30.7957 | 25.1413 | 23.88 |
Benitec Biopharma and related stocks such as Bio Path Holdings, Catalyst Biosciences, and Diffusion Pharmaceuticals Sales General And Administrative To Revenue description
My Equities
My Current Equities and Potential Positions
| Benitec Biopharma Ltd | BNTC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Australia |
| Exchange | NASDAQ Exchange |
USD 9.85
Check out Benitec Biopharma Performance and Benitec Biopharma Correlation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Benitec Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.